[June 21, 2016]

Roche/Blueprint Medicines Deal Highlights Big Pharma's Increased Willingness to Sign High-Value Deals with Narrow Focus Companies - Research and Markets

Research and Markets has announced the addition of the "Biosimilars Business Review Issue 34" report to their offering.

The Roche/Blueprint Medicines deal highlights big pharma's increased willingness to sign high-value deals with narrow focus companies that offer innovative agility at a level not found in-house. For Roche the deal strengthens the outlook for its long-term oncology dominance. For Blueprint, the deal provides validation of the young company's core approach, providing support for growth.

Key Topics Covered:

1. More Work Necessary For WHO To Break Biosimilar Naming Stalemate
2. BsUFA Reauthorisation Meeting Highlights Shortfalls In US Biosimilar Programme
3. Data From Biosimilar Infliximab Study Presented
4. Momenta Agreement Adds To Momentum (News - Alert) Propelling Mylan Into Biosimilar Sphere
5. Sorrento Biosimilars Show Positive Phase III Results
6. Xbrane Enters Ranibizumab Deal With elvetic BioPharma
7. Torrent Launches Adalimumab Biosimilar
8. Marketing Will Be Key To Creating A Viable Biosimilar Etanercept Niche
9. Biocad To Supply Anticancer Biosimilars Outside Russia
10. Biocad's Trastuzumab Approved In Russia
11. Lek Opens New Laboratory In Menges
12. Kyowa Hakko Kirin Enters Rituximab Agreement With Sandoz
13. Positive Phase III Results Reported For CHS-0214
14. FDA Accepts Amgen's Biosimilar Adalimumab For Review
15. Market Conditions Challenge Sandoz But Biosimilars Provide Optimism
16. CMS Biosimilar Reimbursement Rule Highlights Need For Interchangeability Guidance
17. FDA Budget Request Takes Aim At Pay-For-Delay Agreements
18. Pfizer Edges Towards US Biosimilar Infliximab Dominance
19. EMA (News - Alert) Accepts Sandoz' Biosimilar Pegfilgrastim Submission
20. JHL Gains European Rituximab Trial Approval
21. Sandoz Acquires Pfizer's Infliximab In EEA
22. Merck KGaA Trial Highlights Growing Potential Biosimilar Adalimumab Market
23. Gedeon Richter Expands Debrecen Biotech Plant
24. Dr Reddy's Enters Biosimilars Collaboration With TR-Pharm
25. EGA Changes Name To Medicines For Europe

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160621006010/en/

[ Back To TMCnet.com's Homepage ]